AU4686189A - New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom - Google Patents

New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom

Info

Publication number
AU4686189A
AU4686189A AU46861/89A AU4686189A AU4686189A AU 4686189 A AU4686189 A AU 4686189A AU 46861/89 A AU46861/89 A AU 46861/89A AU 4686189 A AU4686189 A AU 4686189A AU 4686189 A AU4686189 A AU 4686189A
Authority
AU
Australia
Prior art keywords
new pharmaceutical
regentation
syndrom
leukocytes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46861/89A
Inventor
Francois Dietlin
Daniele Fredj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scr Newpharm
Original Assignee
S C R NEWPHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S C R NEWPHARM filed Critical S C R NEWPHARM
Publication of AU4686189A publication Critical patent/AU4686189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU46861/89A 1988-12-19 1989-12-19 New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom Abandoned AU4686189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR888816749A FR2640508B1 (en) 1988-12-19 1988-12-19 NOVEL COMPOSITIONS AND NEW PHARMACEUTICAL PRODUCTS ENSURING THE REGENERATION OF LEUKOCYTES AND THEIR USE FOR THE TREATMENT OF IMMUNE DEFICIT SYNDROME
FR8816749 1988-12-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU39806/93A Division AU666725B2 (en) 1988-12-19 1993-05-25 New pharmaceutical compositions and new pharmaceutical products allowing the regeneration of leukocytes and their use in the treatment of acquired immuno-deficient syndrom

Publications (1)

Publication Number Publication Date
AU4686189A true AU4686189A (en) 1990-06-21

Family

ID=9373109

Family Applications (2)

Application Number Title Priority Date Filing Date
AU46861/89A Abandoned AU4686189A (en) 1988-12-19 1989-12-19 New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom
AU39806/93A Expired - Fee Related AU666725B2 (en) 1988-12-19 1993-05-25 New pharmaceutical compositions and new pharmaceutical products allowing the regeneration of leukocytes and their use in the treatment of acquired immuno-deficient syndrom

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU39806/93A Expired - Fee Related AU666725B2 (en) 1988-12-19 1993-05-25 New pharmaceutical compositions and new pharmaceutical products allowing the regeneration of leukocytes and their use in the treatment of acquired immuno-deficient syndrom

Country Status (19)

Country Link
EP (1) EP0375471B1 (en)
JP (1) JPH02258722A (en)
KR (1) KR900009075A (en)
AP (1) AP125A (en)
AT (1) ATE136463T1 (en)
AU (2) AU4686189A (en)
CA (1) CA2005925C (en)
DE (1) DE68926222D1 (en)
DK (1) DK646489A (en)
FR (1) FR2640508B1 (en)
HU (1) HU213510B (en)
IL (1) IL92759A (en)
MA (1) MA21964A1 (en)
MY (1) MY106032A (en)
NZ (1) NZ231854A (en)
OA (1) OA09250A (en)
PT (1) PT92620B (en)
TN (1) TNSN89135A1 (en)
ZA (1) ZA899733B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine
EP0509401A1 (en) * 1991-04-19 1992-10-21 Hoechst-Roussel Pharmaceuticals Incorporated Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
RU2036198C1 (en) * 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
WO1988003804A2 (en) * 1986-11-21 1988-06-02 Max-Planck-Gesellschaft Zur Förderung Der Wissensc Method of treating viral infections in humans and compositions therefor
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
CH678275A5 (en) * 1989-05-25 1991-08-30 Debiopharm Sa
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US4999430A (en) * 1989-07-31 1991-03-12 Warner-Lambert Company Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Also Published As

Publication number Publication date
ZA899733B (en) 1991-04-24
FR2640508A1 (en) 1990-06-22
AP8900157A0 (en) 1990-01-31
TNSN89135A1 (en) 1991-02-04
PT92620A (en) 1990-06-29
PT92620B (en) 1995-09-12
DE68926222D1 (en) 1996-05-15
HU213510B (en) 1997-07-28
OA09250A (en) 1992-06-30
EP0375471A2 (en) 1990-06-27
CA2005925A1 (en) 1990-06-19
DK646489A (en) 1990-06-20
MY106032A (en) 1995-02-28
DK646489D0 (en) 1989-12-19
HU896683D0 (en) 1990-02-28
ATE136463T1 (en) 1996-04-15
AU3980693A (en) 1993-08-19
JPH02258722A (en) 1990-10-19
KR900009075A (en) 1990-07-02
EP0375471A3 (en) 1992-07-08
CA2005925C (en) 2002-03-26
AU666725B2 (en) 1996-02-22
AP125A (en) 1991-03-19
MA21964A1 (en) 1991-07-01
FR2640508B1 (en) 1994-07-01
EP0375471B1 (en) 1996-04-10
IL92759A (en) 1994-06-24
IL92759A0 (en) 1990-09-17
NZ231854A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
IL91069A (en) Intravenous pharmaceutical compositions and their preparation
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
IL84946A0 (en) Drug delivery compositions and their preparation
AU8589591A (en) Materials useful in human and veterinary medicine
EP0304802A3 (en) Pharmaceutical composition and the use thereof
IL92138A0 (en) Pharmaceutical compositions containing piroxicam and their preparation
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
AU8316587A (en) Pharmaceutical compositions and their use
IL89778A (en) Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them
IL88404A0 (en) Neutrophil activating factor,its preparation and pharmaceutical compositions containing it
AU4819690A (en) Use of pyrithione-containing polymers as antimicrobial agents in personal care products
AR244720A1 (en) Esterified glycidylether-addition products and their use
GB9022572D0 (en) Use of glycoprotein extracts of gram(-)bacteria for the manufacture of comestic or dermatological compositions and compositions containing them
AU4686189A (en) New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
GB2221464B (en) Oxaza heterocycles and their use in pharmaceutical compositions
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
GB9110445D0 (en) Improvements in and relating to the manufacture of dough products
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
AU4158185A (en) A pharmaceutical product having an anti-tumor activity; the use of a pharmaceutical product or of pharmaceutical compositions in an anti-tumor therapy